|Articles|December 1, 2017
- Pharmaceutical Executive-12-01-2017
- Volume 37
- Issue 12
Pharmaceutical Executive, December 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive December 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 8 years ago
Global Health: Fighting the Good Fightabout 8 years ago
Global Health: Partnerships Hold the Keyover 8 years ago
First Foray into Digital Adherenceover 8 years ago
Global Health: Messages of Hopeover 8 years ago
A Year of Transformation for Science & Medicineover 8 years ago
Access and Reimbursement for Adoptive T-Cell Transfer Drugsover 8 years ago
Will Europe Turn a Corner in Personalized Medicine?over 8 years ago
Fulfilling the Vision of Science: AstraZeneca's Ruud Dobberover 8 years ago
Country Report: CanadaNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Wegovy HD Injectable Under Accelerated Approval
2
TrumpRx Selling Medicines at Higher Prices Than Other Countries: Report
3
Pharma M&A Roundup: Novartis to Acquire Pan-Mutant-Selective PI3Kα Inhibitor from Synnovation Therapeutics, Collegium to Acquire Azstarys from Corium Therapeutics
4
What Are the ‘Last Mile Issues’ Impacting Pharma?
5